Substance / Medication

Dexamethasone phosphate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

26 trials linked to this intervention

26
Total Trials
4
Recruiting
6
With Results

Research Evidence

Published studies and systematic reviews

Sort:
1,25-dihydroxyvitamin D-mediated hypercalcemia associated with solid organ malignancy: a systematic review.
Charoenngam Nipith, Ponvilawan Ben, Rujirachun Pongprueth et al. · Minerva Endocrinol (Torino) · 2025
PMID: 34581546Meta-Analysis
Woringer-Kolopp disease (localized pagetoid reticulosis): a systematic review.
Osto Muhammad, Afify Omar, Musa Arif et al. · Int J Dermatol · 2023
PMID: 35485962Meta-Analysis
Topical chlormethine gel in the treatment of mycosis fungoides: A single-center real-life experience and systematic review of the literature.
Laghi Alessandro, Franceschini Chiara, Mandel Victor Desmond et al. · Dermatol Ther · 2022
PMID: 35778940Meta-Analysis
Intravitreal aflibercept alone versus combination with dexamethasone phosphate for diabetic macular edema: A randomized phase-2 clinical trial.
Neri Valesca Castro, Lira Rodrigo Pessoa Cavalcanti, Vasconcelos Andrea Andrade Azevedo de et al. · Arq Bras Oftalmol · 2025
PMID: 40699120RCT
Iontophoretic Dexamethasone Phosphate Compared to Topical Prednisolone Acetate 1% for Noninfectious Anterior Segment Uveitis.
Sheppard John, Garg Sunir, Lievens Christopher et al. · Am J Ophthalmol · 2020
PMID: 31726034Trial
Evaluation of dexamethasone phosphate delivered by ocular iontophoresis for treating noninfectious anterior uveitis.
Cohen Amy E, Assang Carol, Patane Michael A et al. · Ophthalmology · 2012
PMID: 22115712Trial
Failure to detect dexamethasone phosphate in the local venous blood postcathodic lontophoresis in humans.
Smutok Michael A, Mayo Michele F, Gabaree Catherine L et al. · J Orthop Sports Phys Ther · 2002
PMID: 12322812Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Dexamethasone phosphate (substance)
SNOMED CT
396016009
UMLS CUI
C0770565

Clinical Data

This intervention maps to 25 entities in the Ltrl knowledge graph.

20
Conditions
2
Biomarkers
2
Specialists
0
Symptoms
26
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.